À l'heure de la deuxième pause, le Lausanne HC (2e), Fribourg-Gottéron (3e) et Genève-Servette (5e) sont bien installés parmi ...

Fondé en 2007, l’organisme de formation s’appuie sur un réseau de plus de 2 500 formateurs, intervient en présentiel partout ...

Les espoirs d'Anderlecht sont présents à la Premier League International Cup. Ils ont brillé en venant à bout de Manchester ...

As a young man, I was privileged to be an eyewitness to the rise of the Christian spiritual formation movement. It began, in its modern form, in 1978, when Richard Foster wrote what has become the ...

Having secured one of last year’s largest funding rounds, AI-focused Formation Bio is now eyeing up 545 million euros ($626 million) in potential paydays from a licensing deal with Sanofi. The French ...

Spiritual formation shouldn’t be an attempt to control ministry outcomes—it’s about cultivating space for God to work. I recently read about a spiritual formation program that went terribly wrong. A ...

EXCLUSIVE: Atlanta-based talent agency People Store has rebranded as Formation Talent Agency, brining in veteran agent Lauren Williams to serve as Senior Vice President of Talent amidst this evolution ...

Le BIM, acronyme pour Building Information Modeling, est une démarche de gestion de projet en construction. Grâce à elle, les différents acteurs d'un projet peuvent collaborer autour d’une maquette ...

It took just one game of the 2024 season to land NFL officiating back in the discourse. On the second play of Thursday night's game between the Kansas City Chiefs and Baltimore Ravens, referee Shawn ...

The Ravens scored the first touchdown of the 2024 NFL season when Derrick Henry plowed into the end zone on a five-yard run. It came despite some early struggles with illegal formation penalties.

June 26 (Reuters) - AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker Sanofi ...

Formation Bio, a startup focused on applying AI to drug development with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to support its ambitious product roadmap.